Corticosteroid Use in Peritoneal Tuberculosis
Corticosteroids are not indicated for routine treatment of peritoneal tuberculosis (TB). [1] Corticosteroids are recommended in specific severe TB syndromes, including tuberculous meningitis, and may be used for tuberculous pericarditis. [2]
Guideline Indications for Adjunctive Corticosteroids
WHO guidance supports adjunctive corticosteroids for tuberculous meningitis and allows use for tuberculous pericarditis. [1] WHO guidance states that there are no WHO recommendations regarding corticosteroids for extrapulmonary TB forms other than tuberculous meningitis and tuberculous pericarditis. [1]
Extrapulmonary Tuberculosis Forms Without Specific Corticosteroid Recommendations
A review of extrapulmonary TB states that there are insufficient data to recommend adjunctive corticosteroid therapy in peritoneal TB. [3]
Evidence-Based Clinical Position for Peritoneal TB
Adjunctive corticosteroid therapy is not recommended as routine management for abdominal TB. [4]
Practical Clinical Implication for Peritoneal TB
Antituberculous therapy remains the core treatment for peritoneal TB. [3] Corticosteroids should not be used as routine adjunctive therapy for peritoneal TB outside guideline-supported indications. [1]
When Corticosteroids May Still Be Considered
Corticosteroids may be considered when complications or alternative indications exist that are not addressed by peritoneal TB-specific guideline recommendations. [1] Corticosteroid use for TBM is supported by a strong recommendation in the ATS/CDC/IDSA drug-susceptible TB guideline. [2]
Common Pitfall
Routine corticosteroid use in abdominal TB syndromes beyond tuberculous meningitis and tuberculous pericarditis is not supported by guideline-directed recommendations and evidence summaries. [1], [3], [4]